Objectives: Bovine pericardial patches (BPP) are increasingly used during femoral and carotid endarterectomies (CEA), and owing to handling and sonographic properties, have become our patch material of choice in recent years. However, the long-term performance of this material compared with other CEA closure strategies remains poorly defined. We sought to determine how infection and bleeding complications after CEA performed with BPP compared with CEA performed with Dacron patches or primary closure (PC).
Methods: All consecutive CEA performed between January 1, 1996, and December 31, 2008, at a single institution were entered real-time into a relational database.
Results: During the 12-year study period, 1331 CEAs were performed (Table) . Mean follow-up was 1412 days (median, 1147 days). There were no statistically significant differences in the rates of postoperative wound infection, hematoma, stroke, or 30-day mortality in the three groups. Five-year patency was significantly improved with BPP and Dacron patches compared with PC. Five-year survival was also enhanced with BPP compared with Dacron patches and PC.
Conclusions: In this nonconcurrent cohort study, which represents the largest reported experience with BPP during CEA to date, the rate of postoperative bleeding and infection complications with BPP was similar to that with Dacron patching and PC. Beyond equivalent clinical performance, our data suggest BPP is associated with increased long-term survival. Objectives: By Centers for Medicare and Medicaid Services (CMS), carotid artery stenting (CAS) patients are high surgical risk. We evaluated mortality and stroke after CEA and CAS combined with and without coronary artery bypass grafting/valve surgery (CABG/V) and adjusted for medical high-risk criteria.
Stroke and Death after Carotid Endarterectomy and Carotid Artery
Methods: The Nationwide Inpatient Sample (2004 Sample ( -2006 was queried by International Classification of Diseases, 9th Revision, codes for CEA and CAS with diagnosis of carotid artery stenosis. CABG/V procedures were also identified. Symptom status was defined by history of stroke, transient ischemic attack (TIA), and/or amaurosis fugax. Postoperative stroke was defined by coding for postoperative complications (997.02).
Results: We identified 367,255 CEA (90%) and 40,404 CAS (10%). CABG/V was performed more commonly with CEA than CAS (2.9% vs 1.0%, P Ͻ .001). Demographics and comorbidities are summarized in Table  I . Patients undergoing CAS alone or CAS with CABG/V were more likely symptomatic (13.6% vs 13.3%) than those undergoing CEA alone or CEA with CABG/V (9.6% vs 6.9%; P Ͻ .001 vs P Ͻ .05). Mortality was 0.6% for carotid intervention alone and 4.1% for tandem CABG/V (P Ͻ .001). Stroke occurred in 1.0% of carotid procedures alone and in 3.4% of CABG/V. Stroke or death was 1.4% for CEA vs 3.6% for CAS alone and 7.0% for CEA vs 11.4% for CAS with CABG/V. Multivariate predictors of stroke or death included age, symptom status, congestive heart failure, 
